Maplewood, Minnesota-headquartered Solventum Corporation (SOLV) is a global healthcare company that develops medical technologies, products, and software to improve patient outcomes and streamline healthcare delivery. It currently has a market cap of $13.7 billion.
The healthcare company is expected to announce its Q2 2026 earnings on Wednesday, Aug. 5, after the market closes. Ahead of the event, analysts expect SOLV to report a profit of $1.91 per share on a diluted basis, up 13% from $1.69 per share in the year-ago quarter. The company beat the consensus estimates in each of the past four quarters, which is noteworthy.
